Overview
Marco Tagliamento practices practicing medicine in Villejuif, France.
Mr. Tagliamento is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), COVID-19, BRCA Positive Breast Cancer, and Hormone Replacement Therapy (HRT).
He is actively involved in clinical research, co-authoring 103 peer reviewed articles.
Gender
Locations
Villejuif, 94805, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marco Tagliamento
Is Marco Tagliamento a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Marco Tagliamento is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marco Tagliamento participate in research or clinical trials?
Yes. Marco Tagliamento has published 103 articles and abstracts on conditions like Lung Cancer. You can view a list of Marco Tagliamento's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- COVID-19Mr. Tagliamento isDistinguished. Learn about COVID-19.
- Lung CancerMr. Tagliamento isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Tagliamento isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- BRCA Positive Breast CancerMr. Tagliamento isAdvanced. Learn about BRCA Positive Breast Cancer.
- Experienced
- Breast CancerMr. Tagliamento isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerMr. Tagliamento isExperienced. Learn about EGFR Positive Lung Cancer.
- HepatitisMr. Tagliamento isExperienced. Learn about Hepatitis.
- Hepatitis CMr. Tagliamento isExperienced. Learn about Hepatitis C.
- Hormone Replacement Therapy (HRT)Mr. Tagliamento isExperienced. Learn about Hormone Replacement Therapy (HRT).
- Kienbock's DiseaseMr. Tagliamento isExperienced. Learn about Kienbock's Disease.
- MenopauseMr. Tagliamento isExperienced. Learn about Menopause.
- MesotheliomaMr. Tagliamento isExperienced. Learn about Mesothelioma.
- OsteonecrosisMr. Tagliamento isExperienced. Learn about Osteonecrosis.
- PIK3CA-Related Overgrowth SpectrumMr. Tagliamento isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- PneumoniaMr. Tagliamento isExperienced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)Mr. Tagliamento isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Thymic Epithelial TumorMr. Tagliamento isExperienced. Learn about Thymic Epithelial Tumor.